(Golimumab: Drug Information from Uptodate)
Rheumatoid arthritis: Note: For use as adjunctive therapy in patients who have not met treatment goals despite maximally tolerated methotrexate therapy; may also be used off-label as an alternative to methotrexate in DMARD-naive patients with moderate to high disease activity.
IV: 2 mg/kg at weeks 0, 4, and then every 8 weeks thereafter (in combination with methotrexate).
SubQ: 50 mg once a month (in combination with methotrexate).